Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Wilms Tumor 6Osteosarcoma 6Neuroblastoma 6Leukemia, Myeloid, Acute 6Glioma 6Rhabdoid Tumor 5Neoplasm Metastasis 5Lymphoma, Non-Hodgkin 5Hepatoblastoma 5Sarcoma 4Rhabdomyosarcoma 4Neuroectodermal Tumors, Primitive, Peripheral 4Multiple Myeloma 4Medulloblastoma 4Histiocytosis, Langerhans-Cell 4Ependymoma 4Colorectal Neoplasms 4Carcinoma, Hepatocellular 4Breast Neoplasms 4Sarcoma, Ewing 3Prostatic Neoplasms 3Ovarian Neoplasms 3Myelodysplastic Syndromes 3Lymphoma 3Lung Neoplasms 3Endometrial Neoplasms 3Central Nervous System Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Mouth Neoplasms 2Melanoma 2

Interventions

Specimen Handling 4Doxorubicin 4pembrolizumab 3Magnetic Resonance Spectroscopy 3Biopsy 3pazopanib 2palbociclib 2Radiotherapy 2Radiation 2Ifosfamide 2talimogene laherparepvec 1selinexor 1ribociclib 1peposertib 1mirdametinib 1liposomal doxorubicin 1cemiplimab 1abemaciclib 1X-Rays 1Surgical Procedures, Operative 1Proton Therapy 1Neoadjuvant Therapy 1Immunoglobulin G 1Histamine H2 Antagonists 1Gemcitabine 1Famotidine 1Everolimus 1Docetaxel 1Angptl4 protein, mouse 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liposarcoma × X-Rays × 30 days × Clear all
NCT06422806 2026-05-26

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

National Cancer Institute (NCI)

Phase 3 Recruiting
365 enrolled
Sarcoma

Liposarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡